| abstract |
The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1 n n n n n n n n n n wherein n R 1 is H, C 1-6 -alkyl, C 0-4 -alkyl-C 3-6 -cycloalkyl, C 1-6 -haloalkyl; n R 2 is H, C 1-6 -alkyl; n X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate n j is 1 or 2.n nprocesses for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor |